Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. [electronic resource]
Producer: 20031029Description: 2345-50 p. digitalISSN:- 0006-4971
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carmustine -- administration & dosage
- Case-Control Studies
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Genetic Variation
- Genotype
- Glutathione S-Transferase pi
- Glutathione Transferase -- genetics
- Humans
- Incidence
- Isoenzymes -- genetics
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Polymorphism, Genetic
- Prednisolone -- administration & dosage
- Survival Rate
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.